Author

K. Polak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein sequence· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Bouzid· 1 shared A.-L. Chaves Valadao· 1 shared B. Trentin· 1 shared C. Bertrand-Gaday· 1 shared C. Gongora· 1 shared C. Taffoni· 1 shared D. Merle· 1 shared D. Pineau· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bouzid

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The crosstalk between DNA-PK and cGAS drives tumor immunogenicity

C. Taffoni, J. Marines, H. Chamma, M. Saccas, A. Bouzid, S. Guha, A.-L. Chaves Valadao, K. Polak, M. Del Rio, C. Gongora, D. Pineau, J.-P. Hugnot, K. Kissa, L. Fontenille, F. P. Blanchet, , N. Laguette

This study shows DNA-PK and cGAS work together to drive inflammation in tumors, affecting immunogenicity and patient outcomes.

bioRxiv · Jun 8, 2022 · PreprintCancer Biology

Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice.

K. Polak, N. Greze, M. Lachat, D. Merle, S. Chiumento, C. Bertrand-Gaday, B. Trentin, R. Z. Mamoun

This study develops an EV-based vaccine platform that displays native SARS-CoV-2 Spike proteins, inducing strong anti-viral responses in mice without adjuvants.

bioRxiv · Oct 28, 2020 · PreprintImmunology